2018 NASH-TAG CONFERENCE

PRESENTATION SLIDES

Click the presentation titles to view and download the accompanying slide deck as a PDF

FRIDAY, JANUARY 5, 2018

SESSION 1: LATEST CLINICAL TRIAL RESULTS

FGF 21 Agonist

Presenter: Arun Sanyal, MD

FGF 19 Variant

Presenter: Stephen Harrison, MD

SESSION 2: CLINICAL TRIAL DESIGN UPDATES

ALT and Fibrosis Markers

Presenter: Mary Rinella, MD

SESSION 3: EXPERIMENTAL SESSION

Lipotoxicity as a Trigger for
Liver Damage

Presenter: Harmeet Malhi, MD

SATURDAY, JANUARY 6, 2018

SESSION 1: TREATING THE
CIRRHOTIC PATIENT

SESSION 2: NEW PHARMACOLOGICAL
TARGETS

Specifics of Cirrhotic Trials and
Their Objectives

Presenter: Jason Campagna, MD, PhD

SGLT2 Inhibitors

Presenter: Chimweike Ukomadu, MD, PhD

Endoscopic Bariatric Surgery

Presenter: Christopher Chapman, MD

SESSION 3: HEPATIC FIBROSIS: EXPERIMENTAL ADVANCES AND TARGETS FOR THERAPY

© 2020 by Focus Medical Communications, Inc.

  • Facebook Social Icon
  • Twitter Social Icon
  • LinkedIn Social Icon